Notable Labs Share Holder Equity 2013-2024 | NTBLQ
Notable Labs share holder equity from 2013 to 2024. Share holder equity can be defined as the sum of preferred and common equity items
Notable Labs Annual Share Holder Equity
(Millions of US $) |
| 2023 |
$15 |
| 2022 |
$-37 |
| 2021 |
$51 |
| 2020 |
$31 |
| 2019 |
$36 |
| 2018 |
$53 |
| 2017 |
$56 |
| 2016 |
$42 |
| 2015 |
$35 |
| 2014 |
$35 |
| 2013 |
$-24 |
| 2012 |
$0 |
Notable Labs Quarterly Share Holder Equity
(Millions of US $) |
| 2024-06-30 |
$7 |
| 2024-03-31 |
$12 |
| 2023-12-31 |
$15 |
| 2023-09-30 |
$18 |
| 2023-06-30 |
$19 |
| 2023-03-31 |
$20 |
| 2022-12-31 |
$-37 |
| 2022-09-30 |
$25 |
| 2022-06-30 |
$34 |
| 2022-03-31 |
$43 |
| 2021-12-31 |
$51 |
| 2021-09-30 |
$49 |
| 2021-06-30 |
$54 |
| 2021-03-31 |
$36 |
| 2020-12-31 |
$31 |
| 2020-09-30 |
$37 |
| 2020-06-30 |
$43 |
| 2020-03-31 |
$31 |
| 2019-12-31 |
$36 |
| 2019-09-30 |
$41 |
| 2019-06-30 |
$45 |
| 2019-03-31 |
$50 |
| 2018-12-31 |
$53 |
| 2018-09-30 |
$57 |
| 2018-06-30 |
$61 |
| 2018-03-31 |
$50 |
| 2017-12-31 |
$56 |
| 2017-09-30 |
$30 |
| 2017-06-30 |
$35 |
| 2017-03-31 |
$38 |
| 2016-12-31 |
$42 |
| 2016-09-30 |
$47 |
| 2016-06-30 |
$49 |
| 2016-03-31 |
$31 |
| 2015-12-31 |
$35 |
| 2015-09-30 |
$24 |
| 2015-06-30 |
$30 |
| 2015-03-31 |
$32 |
| 2014-12-31 |
$35 |
| 2014-09-30 |
$3 |
| 2014-06-30 |
$0 |
| 2014-03-31 |
$0 |
| 2013-12-31 |
$-24 |
| 2013-09-30 |
|
| 2012-12-31 |
$0 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.000B |
$0.000B |
|
Notable Labs Ltd. is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Notable Labs Ltd., formerly known as Vascular Biogenics Ltd., is based in FOSTER CITY, Calif.
|
